Boston Archives - Medical Design Sourcing

The MedTech Conference is coming to Boston in 2022

[Boston image from Unsplash]Trade group AdvaMed plans to return to an entirely in-person event for The MedTech Conference, with the annual event slated for Boston on October 24–26, 2022.

AdvaMed in September 2021 held a hybrid event that included virtual sessions as well as live sessions in Minneapolis and Washington, D.C. (The year before — in pre-COVID vaccine times — the event was entirely virtual.)

“We recognized the strong desire to gather in-person at our 2021 hybrid conference, and will continue to plan for a live event while closely monitoring the status of COVID-19 in the coming months. Rest assured, the safety of our staff and attendees remains our top priority,” AdvaMed EVP Ray Briscuso and SVP Wendy Siminski said in an announcement yesterday.

MassDevice and Medical Design & Outsourcing‘s DeviceTalks is also returning in 2022 with live events: Boston May 10–11, Minneapolis June 6–7, and Santa Clara, California October 19–20.

The MedTech Conference is coming to Boston in 2022

[Boston image from Unsplash]

Trade group AdvaMed plans to return to an entirely in-person event for The MedTech Conference, with the annual event slated for Boston on October 24–26, 2022.

AdvaMed in September 2021 held a hybrid event that included virtual sessions as well as live sessions in Minneapolis and Washington, D.C. (The year before — in pre-COVID vaccine times — the event was entirely virtual.)

“We recognized the strong desire to gather in-person at our 2021 hybrid conference, and will continue to plan for a live event while closely monitoring the status of COVID-19 in the coming months. Rest assured, the safety of our staff and attendees remains our top priority,” AdvaMed EVP Ray Briscuso and SVP Wendy Siminski said in an announcement yesterday.

MassDevice and Medical Design & Outsourcing‘s DeviceTalks is also returning in 2022 with live events: Boston May 10–11, M…

Report: 20,000 COVID cases traced to Boston medtech company’s conference

The “super-spreading” event held by Biogen (NSDQ:BIIB) in February reportedly led to approximately 20,000 COVID-19 cases across four Massachusetts counties.

According to a Boston Globe report, the international company meeting at the Marriott Long Wharf hotel in Boston was said to have resulted in 99 identified cases of the virus, but, according to scientists studying early cases, that number reached roughly 20,000 by early May in those four counties.

Researchers studied all confirmed early cases of COVID-19 in the area by changes in the genetic makeup of coronaviruses to gauge the spread of the event hosted by Cambridge, Mass.-based Biogen, according to The Globe.

Almost all of the 772 cases observed came from Essex, Middlesex, Norfolk and Suffolk counties. Through observing mutations in the genetic code of the viruses, the researchers identified more than 80 distinct SARS-CoV-2 genomes that spread around the Boston area, the report says. Read more

The hottest life science hubs in the U.S.

Boston at night [Photo by Lance Anderson on Unsplash]

Boston, San Francisco and San Diego remain the leading U.S. life science hubs — hauling in 70% of all the venture capital in the space last year, according to a new report from commercial real estate services company JLL.

Venture capital funding matters, according to JLL, because it fuels innovative companies that then require more real estate space. It’s little wonder that Boston and San Francisco led other clusters with respect to development, with 2.7 million square feet and 4.0 million square feet respectively under construction.

Get the full story on our sister site Medical Design & Outsourcing.

The hottest life science hubs in the U.S.

Boston at night [Photo by Lance Anderson on Unsplash]

Boston, San Francisco and San Diego remain the leading U.S. life science hubs — hauling in 70% of all the venture capital in the space last year, according to a new report from commercial real estate services company JLL.

Venture capital funding matters, according to JLL, because it fuels innovative companies that then require more real estate space. It’s little wonder that Boston and San Francisco led other clusters with respect to development, with 2.7 million square feet and 4.0 million square feet respectively under construction.

The U.S. is struggling through the COVID-19 pandemic and resulting recession. But JLL in its “2020 Life Sciences Real Estate Outlook” report expressed optimism when it comes to the life sciences sector. Key points in the report included:

The pandemic has sparked a race to create coronavirus tests, t…